title: Control of in vitro prostaglandin F2 alpha and E2 synthesis by caruncular and allantochorionic tissues from cows that calved normally and those with retained fetal membranes.
abstract: High concentrations of PGF2 alpha and PGE2 are produced by the uterus during the early postpartum period in cows and may play an important role in both placental separation and uterine involution. In the present study, we have examined the hormonal and intracellular control mechanisms involved in PGF2 alpha and PGE2 secretion by caruncular and allantochorionic tissue in vitro. Tissue explants, obtained about 6 hr postpartum from cows that delivered normally (NFM, n = 10) or cows with retained fetal membranes (RFM, n = 4), were incubated for 6 hr and PGF2 alpha and PGE2 concentrations in the medium were determined by radioimmunoassay. Addition of oxytocin (100 microU/ml), platelet activating factor (PAF, 100 ng/ml) and epidermal growth factor (EGF, 100 ng/ml) had no effect on secretion of PGF2 alpha from the caruncle, but oxytocin and PAF did stimulate PGE2. There was no difference between groups of cows. All three substances stimulated PGF2 alpha from the allantochorion of NFM, but not RFM, cows and stimulated PGE2 secretion from the allantochorion of both groups of cows. Incubation of the tissues with cholera toxin (100 ng/ml), dibutyryl cyclic adenosine 3',5'-monophosphate (dibutyryl cAMP, 1 mM), calcium ionophore A23187 (5 microM) or phorbol ester 12-myristate-13 acetate (PMA, 100 nM) showed that PGF2 alpha secretion is essentially via the calcium-protein kinase C effector pathway. However, calcium-protein kinase C and cAMP second messenger systems appear to be involved in the secretion of PGE2. Prostaglandin secretion was sensitive to cycloheximide in both caruncular and allantochorionic tissues, suggesting that protein synthesis may be involved. In conclusion, these data show that in vitro PGF2 alpha secretion can be modulated by the agonists used only in allantochorion and is essentially via the calcium-protein kinase C effector pathway. PGE2 secretion can be modified in both caruncular and allantochorion tissues and involves both inositol triphosphate-diacylglycerol and cAMP second messenger systems.
authors.affiliation: Département de Médecine, Faculté de Médecine Vétérinaire, Université de Montréal.
authors.forename: H
authors.initials: H
authors.lastname: Slama
authors.forename: D
authors.initials: D
authors.lastname: Vaillancourt
authors.forename: A K
authors.initials: AK
authors.lastname: Goff
mesh_terms: D000482:Allantois / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002417:Cattle; D002418:Cattle Diseases / Q000378:metabolism*; D002823:Chorion / Q000187:drug effects / Q000378:metabolism*; D046508:Culture Techniques; D015237:Dinoprost / Q000096:biosynthesis* / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000494:pharmacology; D004958:Estradiol / Q000096:biosynthesis*; D005321:Extraembryonic Membranes; D005260:Female; D007749:Labor Stage, Third; D007744:Obstetric Labor Complications / Q000662:veterinary*; D010121:Oxytocin / Q000494:pharmacology; D010920:Placenta / Q000378:metabolism; D010972:Platelet Activating Factor / Q000494:pharmacology; D011247:Pregnancy; D011493:Protein Kinase C / Q000378:metabolism
chemical_list: D010972:Platelet Activating Factor; D004958:Estradiol; D010121:Oxytocin; D004815:Epidermal Growth Factor; D015237:Dinoprost; D011493:Protein Kinase C; D015232:Dinoprostone; D002118:Calcium